KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Abbott Laboratories (ABT) Shares Outstanding (Weighted Average) (2016 - 2025)

Abbott Laboratories (ABT) has disclosed Shares Outstanding (Weighted Average) for 17 consecutive years, with $1.7 billion as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Weighted Average) changed 0.06% to $1.7 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.7 billion through Dec 2025, changed 0.06% year-over-year, with the annual reading at $1.7 billion for FY2025, 0.06% changed from the prior year.
  • Shares Outstanding (Weighted Average) hit $1.7 billion in Q4 2025 for Abbott Laboratories, roughly flat from $1.7 billion in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $1.8 billion in Q2 2021 to a low of $1.7 billion in Q3 2023.
  • Historically, Shares Outstanding (Weighted Average) has averaged $1.8 billion across 5 years, with a median of $1.7 billion in 2023.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): grew 0.45% in 2021 and later fell 1.36% in 2022.
  • Year by year, Shares Outstanding (Weighted Average) stood at $1.8 billion in 2021, then fell by 1.24% to $1.8 billion in 2022, then dropped by 0.74% to $1.7 billion in 2023, then changed by 0.0% to $1.7 billion in 2024, then rose by 0.06% to $1.7 billion in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for ABT at $1.7 billion in Q4 2025, $1.7 billion in Q3 2025, and $1.7 billion in Q2 2025.